Navigation Links
vRad Goes Live with Visage 7
Date:11/21/2013

San Diego, CA (PRWEB) November 21, 2013

First US health system begins using vRad’s RG2 platform leveraging Visage 7 for primary interpretation

Visage Imaging Inc. (“Visage”), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), announced today that its Visage® 7 Enterprise Imaging Platform has been successfully implemented as part of RG2(SM), vRad’s next-generation radiology operational management solution. RG2—or Radiology Group 2.0—optimizes coverage of both onsite and cloud based radiology services using physician productivity tools such as a next-generation radiology reading platform with Visage’s enterprise diagnostic viewer, global worklists and advanced analytics for faster and better decision making.

vRad (Virtual Radiologic), based in Minneapolis, Minnesota, USA, is the country’s largest radiology group and telemedicine platform. vRad works in partnership with local radiology groups and hospitals to optimize radiology’s pivotal role in patient care. vRad’s more than 450 radiologists serve over 2,000 radiology groups, hospitals and health systems, reading in excess of 7 million studies annually.

“This is an important milestone for us,” said Dr. Sam Hupert, Chief Executive Officer, Visage Imaging and Pro Medicus CEO. “Our technology has proven its capability with a partner operating in a high-volume, high-demand healthcare environment. Not only does it provide vRad radiologists with the most comprehensive set of clinical tools in a single product, but it is also exceptionally fast. Unlike others who have to move ever increasing datasets across the network, we are able to instantly stream the images to radiologists’ desktops regardless of the size of the examination they are reading. Faster delivery means faster diagnoses. That’s a competitive advantage and a critical benefit for the patient communities we serve with our partners.”

“We are extremely pleased with the results of our first go live with Visage,” said Jordan Halter, vRad’s Vice President of Solutions. “RG2 is command central for ground and cloud-based radiology. It’s the future of radiology available today and Visage technology is core to delivering on the promise of ‘read anything, anywhere, anytime.’”

Under the terms of the previously announced agreement, the five-year contract period commences with the first clinical go live, paving the way for further Visage installations within vRad’s extensive national US-based network. “This is a great start for Visage and we are looking forward to further success as vRad continues to roll out its next-generation RG2 platform,” said Dr. Hupert. “We know Visage 7 will provide vRad with a significant strategic advantage in this highly competitive radiology market.”

To easily schedule a priority demonstration and/or meeting at the upcoming RSNA 2013, please visit our new website for additional details.

About Visage Imaging, Inc.

Visage Imaging is a global provider of enterprise imaging and advanced visualization solutions for diagnostic imaging. Visage 7 delivers amazingly fast server-side rendered images streamed via an intelligent thin-client viewer. Radiologists and referring physicians have a customized, protocol-driven workflow to natively view 2D, 3D, 4D and advanced visualization imagery across a single desktop. Powerful imaging solutions include enterprise viewing and interpretation; image enablement of EMRs, VNAs, HIEs and portals; RIS/PACS, as well as anywhere mobile access. http://www.visageimaging.com

About Pro Medicus Limited

Pro Medicus Limited (ASX: PME) is Australia’s leading medical IT and e-health provider. Founded in 1983, the company provides a full range of integrated software products and services to hospital, imaging centers and health care groups worldwide. http://www.promedicus.com

Read the full story at http://www.prweb.com/releases/2013/11/prweb11357598.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Mobile Imaging Access Leaps Ahead with Visage Ease
2. Visage Sculpture, Non-Surgical Face Shaping Cosmetic Practice of Boston, Announces Using Microcannulas to Make Non-Surgical Rhinoplasty Safer
3. Non-surgical Facelift, Specialty of Masha Banar PA-C of Visage Sculpture, Got a "Lift": Retrospective Comparison of Radiesse, Sculptra, and Perlane
4. Masha Banar, PA-C of Visage Sculpture, Non-surgical Face Shaping Cosmetic Practice of Boston, Confirms Resistance Forming to Botox over Time, Less to Dysport.
5. Visage Sculpture, Premiere Cosmetic Clinic of Boston, Reports Shorter-lasting Results of Fillers in Athletes and Offers a Solution
6. VISN23 Selects Visage 7 for Enterprise Imaging
7. Enterprise Imaging Speeds Ahead with Visage 7
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... ... Quality metrics are proliferating in cancer care, and are derived from many ... the beholder, according to experts who offered insights and commentary in the current issue ... the full issue, click here . , For the American Society of Clinical ...
(Date:6/26/2016)... Michigan (PRWEB) , ... June 26, 2016 , ... ... to fertility once they have been diagnosed with endometriosis. These women need a ... they also require a comprehensive approach that can help for preservation of fertility ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , ... Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , ... our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... Fla. (PRWEB) , ... June 24, 2016 , ... Global ... Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition ... Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this year’s ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 2016 One of Australia,s successful ... of a new biotechnology company, Noxopharm Limited [ABN 50 608 966 ... and to list on the ASX. Noxopharm is a ... enter a Phase 1 clinical study later this year. ... of the biggest problems facing cancer patients - the ability of ...
(Date:6/26/2016)... June 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as ... Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) ... Daylight Time). As previously announced on May ... definitive merger agreement under which Jazz Pharmaceuticals has commenced ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
Breaking Medicine Technology: